Beyers Nel, CEO of Harmony Gold, speaking at the London Indaba conference, June 2025. HARMONY Gold has given the green light to its Eva copper project in Australia saying on Monday the project would ...
EL PASO, Texas (KVIA) -- Harmony Public Schools says that a contract worker at the Harmony School of Innovation-El Paso was allegedly involved in inappropriate communication and interactions with a ...
Whether they're "Your Idol" or not, "K-Pop Demon Hunters" have shown us "How It's Done" and taken over the world. So it's no surprise that toys inspired by the movie will soon be lining the shelves.
KPop Demon Hunters HUNTR/X fashion dolls of Rumi, Mira and Zoey are up for pre-order, although fans will have to wait a while before they are released. Mattel, which was recently named by Netflix as a ...
Forbes contributors publish independent expert analyses and insights. I cover Hollywood and entertainment. A three-pack of KPop Demon Hunters HUNTR/X fashion dolls featuring Rumi, Mira and Zoey from ...
After its cannabidiol gel candidate failed a phase 3 trial in fragile X syndrome, Harmony Biosciences has now paused development of the asset in a different genetic disease. Harmony announced in ...
What if your handheld gaming device could transform into a performance powerhouse, rivaling traditional consoles when docked? The ROG Xbox Ally X promises just that. By cranking up its Thermal Design ...
Gold looked a little less attractive this week, and gold stocks paid the price. According to data provided by S&P Global Market Intelligence, shares of Harmony Gold are down 10.5% from the end of last ...
Harmony Biosciences Holdings, Inc. is downgraded from Buy to Hold after a failed Phase 3 trial for ZYN002 in Fragile X syndrome. HRMY's pipeline setback and sNDA rejection raise concerns about ...
CLEVELAND, Ohio - Cleveland city councilman Brian Kazy and other members of the city council will present Bone Thugs -N-Harmony with the third annual The Music Keynote to the City at a ceremony at 3 p ...
Sept 24 (Reuters) - Harmony Biosciences (HRMY.O), opens new tab said on Wednesday its experimental drug for a rare genetic disorder failed to meet the main goal in a late-stage trial, sending its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results